Avelumab Shows Promise in Treating Relapsed Thymoma and Thymic Carcinoma Post-Chemotherapy
A pilot study is investigating the safety and clinical activity of avelumab in patients with thymoma and thymic carcinoma after progression on platinum-based chemotherapy.